Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Argent Biopharma ( (AU:RGT) ) just unveiled an announcement.
Argent Biopharma Limited announced the issuance of 616,000 ordinary fully paid securities to its creditors, which will be quoted on the Australian Securities Exchange (ASX). This move is expected to strengthen the company’s financial position and enhance its market presence, potentially impacting its operations and stakeholder interests positively.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapeutic solutions. The company is known for its commitment to advancing healthcare through cutting-edge research and development.
Average Trading Volume: 78,705
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.44M
For detailed information about RGT stock, go to TipRanks’ Stock Analysis page.